Survival analyses from the ZEBRA study
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference11 articles.
1. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer;Jonat;J. Clin. Oncol.,2002
2. Investigation of menstrual recovery after LH-RH agonist therapy for premenopausal patients with breast cancer;Matsumoto;Breast Cancer,2000
3. Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118,630 in breast and prostate cancer;Nicholson;J. Steroid. Biochem.,1984
4. Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer;Taylor;J. Clin. Oncol.,1998
5. Cyclophosphamide, methotrexate and fluorouracil plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients;Boccardo;J. Clin. Oncol.,2000
Cited by 112 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Estimating the overall survival benefit of adjuvant chemo‐endocrine therapy in women over age 50 with pT1‐2N0 early stage breast cancer and 21‐gene recurrence score ≥26: A National Cancer Database analysis;Cancer Medicine;2023-09-28
2. Molecular Profiling in Early ER + Breast Cancer to Aid Systemic Therapy Decisions;Current Oncology Reports;2023-03-02
3. Anti-Hormonal Therapy in Breast Cancer and Its Effect on the Blood-Brain Barrier;Cancers;2022-10-19
4. Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel;The Oncologist;2022-06-15
5. Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer;Medicine;2021-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3